Merck CEO Frazier says COVID-19 vaccine hype a ‘grave disservice’ to the public esagonowsky Tue, 07/14/2020 – 09:36

U.K. marketing police slam Gilead for claiming Biktarvy tolerability beats GSK rival aliu Tue, 07/14/2020 – 10:02

J&J’s Tremfya grabs psoriatic arthritis nod, setting up a battle with Cosentyx, Taltz and more kblankenship Tue, 07/14/2020 […]

Merck KGaA’s manufacturing group could see billions from COVID-19 work: analyst esagonowsky Tue, 07/14/2020 – 11:23

Medicated chewing gum has been recognized as a new advanced drug delivery method but currently there is no […]

Researchers at MIT and Brigham and Women’s Hospital have designed a new face mask that they believe could […]

What you need to knowMany patients with severe covid-19 experience distressing symptoms, including breathlessness and agitation. Palliation of […]

The drug did not extend progression-free survival in patients with newly diagnosed advanced stage ovarian cancer

The mRNA-based vaccines are currently being evaluated in Phase I/II clinical trials in Germany and the US

COVID-19 deaths could reach 119,000 between September 2020 and June 2021 if no action is taken